- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04541758
Comparing the Efficacy of Conservative Treatment With Minimally Invasive Surgery in the Treatment of Rib Fractures
Comparing the Efficacy of Conservative Treatment With Minimally Invasive Surgery in the Treatment of 2-4 Displaced Rib Fractures:A Prospective Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yang Li, PHD
- Phone Number: 13122109923
- Email: drliyang1991@163.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Unilateral thoracic trauma, fractured ends of rib fractures displaced 2-4 places
- Displaced fracture(CT image shows double displacement of bone cortex) located in the 3rd to 10th rib
- The number of broken ends of displaced fractures is greater than that of undisplaced fractures
- The length of time from injury to hospitalization <24 hours
- Age range(18-70)
- ASA grade I-II
- BMI < 30
- Preoperative partial arterial oxygen pressure >60mmHg, partial arterial carbon dioxide pressure <50mmHg
Exclusion Criteria:
- Difficult airway
- History of esophageal reflux
- Myasthenia gravis
- Abnormal coagulation system
- History of gastrointestinal ulcer or bleeding
- History of anaesthesia related drug allergy
A history of asthma or chronic obstructive emphysema
8. Women during pregnancy
9. Flail chest
10. Combined with severe craniocerebral trauma and external abdominal injuries
11. Recent use of clopidogrel, warfarin and aspirin seriously affects blood clotting
12. Self-administered analgesics after injury
13.Massive hemopneumothorax requires emergency surgery
14. Patients who cannot tolerate surgery
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: surgical treatment
Minimally invasive internal fixation under spontaneous respiratory anesthesia and analgesic treatment and chest strap fixation
|
surgical treatment and Conservative treatment
Conservative treatment
|
EXPERIMENTAL: Conservative treatment
analgesic treatment and chest strap fixation
|
Conservative treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage improvement of lung function FEV1(Forced expiratory volume in one second)
Time Frame: FEV1%(One week after treatment)-FEV1%(Admitted)
|
FEV1(Forced expiratory volume in one second),FEV1% :percentage of the expected value
|
FEV1%(One week after treatment)-FEV1%(Admitted)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage improvement of lung function FVC
Time Frame: FVC%(One week after treatment)-FVC%(Admitted)
|
FVC(forced vital capacity),FVC%:percentage of the expected value
|
FVC%(One week after treatment)-FVC%(Admitted)
|
Percentage improvement of lung function PEF
Time Frame: PEF%(One week after treatment)-PEF%(Admitted)
|
PEF(peak expiratory flow ),PEF%:percentage of the expected value
|
PEF%(One week after treatment)-PEF%(Admitted)
|
Pain index
Time Frame: Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
visual analogue scale,VAS(0-10)0:no pain;10:severe pain
|
Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Pleural effusion
Time Frame: Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Measured by chest CT
|
Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Mortality rate
Time Frame: Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Deaths associated with this study
|
Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Length of hospital stay
Time Frame: Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Length of hospital stay
|
Admitted;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Cost of treatment
Time Frame: One year
|
Sum of all treatment costs
|
One year
|
Chronic pain
Time Frame: Three month after treatment;Half a year;One year
|
Pain lasting more than three months(It is suggested in the related article that pain lasting more than 3 months is chronic pain)visual analogue scale,VAS(0-10)0:no pain;10:severe pain
|
Three month after treatment;Half a year;One year
|
Quality of Life score
Time Frame: One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
The Barthel index of ADL
|
One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Time to resume routine work
Time Frame: One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Time to resume routine work
|
One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Duration of analgesic medication
Time Frame: intraoperative;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Duration of analgesic medication
|
intraoperative;One week after treatment;One month after treatment;Three month after treatment;Half a year;One year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Yi Yang, PHD, Shanghai 6th People's Hospital
- Study Chair: Zongli Gao, PHD, Shanghai 6th People's Hospital
- Study Chair: Yonghong Zhao, PHD, Shanghai 6th People's Hospital
- Study Chair: Weiming Wu, PHD, Shanghai 6th People's Hospital
- Study Chair: Weigang Zhao, PHD, Shanghai 6th People's Hospital
- Study Chair: Tiancheng Zhao, PHD, Shanghai 6th People's Hospital
- Study Chair: Xiang Guo, PHD, Shanghai 6th People's Hospital
- Study Chair: Lei Wang, PHD, Shanghai 6th People's Hospital
- Study Chair: Weiwei He, PHD, Shanghai 6th People's Hospital
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ynlc201908
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery--Complications
-
Duke UniversityWithdrawnSurgical Complications From Surgery | Surgical Complications From Bladder Surgery | Surgical Complications From Bowel Surgery
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
-
University of KwaZuluMedical Research Council, South AfricaCompletedMortality | Surgery | Surgery- ComplicationsSouth Africa, Algeria, Benin, Burundi, Cameroon, Congo, The Democratic Republic of the, Congo, Egypt, Ethiopia, Gambia, Ghana, Kenya, Libyan Arab Jamahiriya, Madagascar, Mali, Mauritius, Namibia, Nigeria, Niger, Senegal, Tanzania, Tog... and more
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Western University, CanadaNot yet recruitingSurgery | Surgery--Complications | Pulmonary Complication
-
Faiza GabaQueen Mary University of London; University of Hertfordshire; University of Aberdeen and other collaboratorsRecruitingGynecologic Cancer | Surgery | Surgery--ComplicationsUnited Kingdom
-
Hacettepe UniversityCompletedSurgery--Complications | Newborn Morbidity | Neonatal SurgeryTurkey
-
Washington University School of MedicineNational Institute of Nursing Research (NINR)CompletedSurgery | Surgery--Complications | Perioperative/Postoperative ComplicationsUnited States
-
Hospices Civils de LyonRecruitingPost-operative Complications After Colorectal Surgery | Post-operative Complications After Gastric Surgery | Post-operative Complications After Bariatric SurgeryFrance
-
Henan Cancer HospitalThe First Affiliated Hospital of Zhengzhou University; Henan Provincial People... and other collaboratorsRecruitingSurgery--ComplicationsChina
Clinical Trials on surgical treatment
-
HealthCore-NERIUniversity of California, San Diego; University of Maryland; University of Alabama... and other collaboratorsTerminated
-
Peking University Third HospitalRecruitingOsteoarthritis, Knee | Anterior Cruciate Ligament RuptureChina
-
Uppsala UniversityCompletedSpinal Fractures
-
Kolding SygehusOdense University Hospital; Karolinska University Hospital; Zealand University... and other collaboratorsRecruitingFracture Humerus of ShaftSweden, Finland, Denmark, Norway
-
Sahlgrenska University Hospital, SwedenActive, not recruitingRupture | Ultrasonography | Acute Disease | Athletic Injuries | Achilles Tendon RuptureSweden
-
Medtronic Neurovascular Clinical AffairsRecruiting
-
AO Innovation Translation CenterRecruitingLong Bone FracturesUnited States, Canada, Australia, Ghana, Chile, China, Germany, India, Pakistan, Venezuela, Spain, Croatia, Greece
-
AO Clinical Investigation and Publishing DocumentationActive, not recruitingFemoral Shaft FractureUnited States, Canada, Switzerland, Germany, Austria
-
Hospital Severo OchoaCompleted
-
University of CologneCompletedOutcome, Fatal | Vertebral Osteomyelitis | Spondylodiscitis